# Retrospective Study of Complicated Pneumonia at the Pediatric Department of the University Hospital of Padua: Experience from 2022 to 2024

**Authors:** Valentina Agnese Ferraro, Fiorenza Alfier, Giulia Brigadoi, Daniele Donà, Luca Marchetto, Benedetta Marino, Alberto Sgrò, Federica Visentin, Andrea Volpe, Stefania Zanconato, Silvia Carraro

PMC · DOI: 10.3390/jcm15030978 · Journal of Clinical Medicine · 2026-01-26

## TL;DR

This study examines complicated pneumonia in children at a hospital in Padua, finding that most cases had good outcomes despite severity.

## Contribution

The study provides insights into clinical management and outcomes of complicated pediatric pneumonia in a specific hospital setting.

## Key findings

- Most patients had necrotizing pneumonia with parapneumonic effusion, and common pathogens included Streptococcus pneumoniae.
- Integrated management led to favorable short- and long-term outcomes, with radiological resolution in 31 days post-discharge.
- Oxygen therapy was required in 77.5% of cases, and invasive ventilation was rare.

## Abstract

Background: Community-acquired pneumonia (CAP) in children may be complicated by necrotizing pneumonia (NP), complicated parapneumonic effusion (CPPE), and lung abscess. These complications prolong hospitalization and require medical and surgical intervention. Objectives. To describe clinical course, diagnostic workup, and management of cCAP (complicated CAP) in children admitted to the Women’s and Children’s Health Department, Padua University Hospital, between January 2022 and September 2024. To identify factors associated with disease severity and evaluate outcomes. Methods: All children hospitalized for cCAP during the study period were included. Data collected comprised clinical features, laboratory and imaging findings, medical and surgical management, and outcomes. Results: Forty patients (mean age 4.4 y; 13.15% of pneumonia admission) were included: 67.5% had NP with CPPE, 22.5% isolated effusion, 10% NP without effusion. All patients were febrile at onset, 62.2% had cough, 32.5% abdominal pain, 30% rhinitis. NP was confirmed by contrast-enhanced chest CT. Thirty patients (75%) had positive microbiological testing, mainly Streptococcus pneumoniae and Streptococcus pyogenes. 77.5% required oxygen therapy (five invasive ventilation and one with ECMO). Median fever duration 18 days (IQR 15–27) with elevated CRP (median peak 300 mg/L). Pleural drainage was performed in 66.7%, fibrinolytics in 17.5%, thoracoscopic decortication in 12.5%, and lobectomy in one patient. Radiological resolution occurred at a median of 31 days post-discharge, with normal pulmonary function at a median of 15 months. Conclusions: Despite pediatric cCAP severity, short- and long-term outcomes are favorable. Early recognition and integrated management are crucial, and further prospective studies are warranted to optimize care and identify severity predictors.

## Linked entities

- **Diseases:** pneumonia (MONDO:0005249), lung abscess (MONDO:0000744)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** febrile (MESH:D000071072), lung abscess (MESH:D008169), NP (MESH:D000071067), effusion (MESH:D000080324), CAP (MESH:D003147), rhinitis (MESH:D012220), Pneumonia (MESH:D011014), cCAP (MESH:D017714), fever (MESH:D005334), cough (MESH:D003371), CPPE (MESH:D008107), abdominal pain (MESH:D015746)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Streptococcus pneumoniae (species) [taxon 1313], Streptococcus pyogenes (species) [taxon 1314], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898779/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898779/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898779/full.md

---
Source: https://tomesphere.com/paper/PMC12898779